Forward P/S Multiple: Silk Road Medical (SILK)

Silk Road Medical, Inc - graphic logo of issuer SILK

Silk Road Medical, Inc. (SILK) implements the unique TCAR minimally invasive technique to combat strokes, leveraging a powerful scientific and technical foundation. US plants ensure the production of carotid artery revascularization systems. The forward P/S trajectory visualizes the impact of these factors, where the value of 5.80 characterizes this level. Growing demand among surgeons due to an aging population supports the company's market positions.

silkroadmed.com - SILK Market Cap to Projected Revenue (period 07/04/2022 - 09/28/2024)

Summary analytical data breakdowns for Silk Road Medical, Inc (SILK)

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Fundamental company analysis:SILK (Silk Road Medical Inc.)
Product sample of Silk Road Medical Inc

This ratio assesses the market value of the asset relative to expected earnings, demonstrating the premium investors are willing to pay per unit of future revenue. The current 5.80 value of the forward price-to-sales ratio reflects the market's priced-in expectations for the expansion of Silk Road Medical, Inc (SILK) and its unique TCAR technology, which creates a technological barrier for competitors in the stroke prevention segment.

Who Silk Road Medical, Inc competes with

Price-to-Projected Revenue Ratio Dexcom CGM DXCM|Penumbra Corp (PEN) - Market Cap to Future Revenue Ratio|Novanta Inc - Forward P/S Multiple|HAE (Haemonetics Corporation) - Market Cap to Projected Revenue|INSP: Forward P/S Multiple|Market Cap to Projected Revenue PRCT|CNMD (CONMED Inc.) - Forward P/S Multiple|Pulse Corp (PLSE) - Market Cap to Expected Sales Ratio|Forward P/S Multiple INMD|Forward P/S Multiple picardmedical.com (PMI)|Forward P/S Multiple SRDX (surmodics.com)|Forward P/S Multiple Senseonics Holdings, Inc. SENS|NPCE - Price-to-Projected Revenue Ratio|TCMD: Price-to-Projected Revenue Ratio|SNWV (Sanuwave Health Inc) - Forward Price-to-Revenue Multiple|Projected Price to Revenue Outset Medical OM|ELMD (SmartVest) - Forward P/S Multiple|Market Cap to Future Revenue Ratio LENSAR Inc. LNSR|Price-to-Projected Revenue Ratio AVITA Medical Inc. (RCEL)|Profound Medical Corporation (PROF) - Projected Price to Revenue|Baird Medical Investment Holdings - Forward Price-to-Revenue Multiple|Forward P/S Multiple EDAP Medical EDAP|Apyx Medical Corp - Forward P/S Multiple|Market Cap to Expected Sales Ratio IceCure Medical ICCM|Pulmonx (LUNG) - Price-to-Projected Revenue Ratio|Future Price to Revenue TELA (TELA Bio Corp)|Price-to-Projected Revenue Ratio cytosorbents.com|Forward Price-to-Revenue Multiple Sensus Healthcare, Inc. (SRTS)|Forward P/S Multiple ZYXI|ECOR - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio vicarioussurgical.com RBOT|IINN: Market Cap to Projected Revenue|ICU - Price-to-Projected Revenue Ratio|iridex.com - Price to Expected Revenue Ratio|INBS: Forward P/S Multiple|XAIR (Beyond Air Inc) - Price-to-Projected Revenue Ratio|Price-to-Projected Revenue Ratio Profusa, Inc.|SSKN (strataskinsciences.com) - Price to Expected Revenue Ratio|Forward Price-to-Revenue Multiple GCTK (GlucoTrack Inc.)|nanovibronix.com - Market Cap to Projected Revenue|venusconcept.com - Forward Price-to-Revenue Multiple|Nuwellis Inc (NUWE) - Market Cap to Future Revenue Ratio|AEMD - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio Asensus Surgical Inc ASXC|AVGR: Forward P/S Multiple|Projected Price to Revenue BioSig Technologies, Inc. BSGM|Forward Price-to-Revenue Multiple CUTR|Price-to-Projected Revenue Ratio KNW|Forward P/S Multiple NARI|NVRO - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio ReShape Lifesciences Inc RSLS